These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 33534236)

  • 21. Coagulation monitoring correlation with heparin dose in pediatric extracorporeal life support.
    Moynihan K; Johnson K; Straney L; Stocker C; Anderson B; Venugopal P; Roy J
    Perfusion; 2017 Nov; 32(8):675-685. PubMed ID: 28693359
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prolonged extracorporeal circulation without heparin. Evaluation of the Medtronic Minimax oxygenator.
    Shanley CJ; Hultquist KA; Rosenberg DM; McKenzie JM; Shah NL; Bartlett RH
    ASAIO J; 1992; 38(3):M311-6. PubMed ID: 1457872
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Anticoagulation for Extracorporeal Life Support: Direct Thrombin Inhibitors and Heparin.
    Coughlin MA; Bartlett RH
    ASAIO J; 2015; 61(6):652-5. PubMed ID: 26309096
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Bivalirudin Dosing Requirements in Adult Patients on Extracorporeal Life Support With or Without Continuous Renal Replacement Therapy.
    Walker EA; Roberts AJ; Louie EL; Dager WE
    ASAIO J; 2019 Feb; 65(2):134-138. PubMed ID: 29538017
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Electron Microscopy as a Tool for Assessment of Anticoagulation Strategies During Extracorporeal Life Support: The Proof Is on the Membrane.
    Beely BM; Campbell JE; Meyer A; Langer T; Negaard K; Chung KK; Cap AP; Cancio LC; Batchinsky AI
    ASAIO J; 2016; 62(5):525-32. PubMed ID: 27258220
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Improvement of bypass circuit biocompatibility: comparison and combination of heparin-coated circuit and nitric oxide gas infusion.
    Hayashi Y; Sawa Y; Hirata N; Nishimura M; Ueda H; Naka Y; Yamaguchi T; Ohtake S; Matsuda H
    J Card Surg; 2002; 17(6):477-84. PubMed ID: 12643456
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Anticoagulation Management during First Five Days of Infant-Pediatric Extracorporeal Life Support.
    Bingham KR; Riley JB; Schears GJ
    J Extra Corpor Technol; 2018 Mar; 50(1):30-37. PubMed ID: 29559752
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Extracorporeal life support without systemic anticoagulation: a nitric oxide-based non-thrombogenic circuit for the artificial placenta in an ovine model.
    Fallon BP; Lautner-Csorba O; Major TC; Lautner G; Harvey SL; Langley MW; Johnson MD; Saveski C; Matusko N; Rabah R; Rojas-Pena A; Meyerhoff ME; Bartlett RH; Mychaliska GB
    Pediatr Res; 2024 Jan; 95(1):93-101. PubMed ID: 37087539
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Impact of anticoagulation strategy and agents on extracorporeal membrane oxygenation therapy.
    Macielak S; Burcham P; Whitson B; Abdel-Rasoul M; Rozycki A
    Perfusion; 2019 Nov; 34(8):671-678. PubMed ID: 31057056
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Extracorporeal life support: the precarious balance of hemostasis.
    Annich GM
    J Thromb Haemost; 2015 Jun; 13 Suppl 1():S336-42. PubMed ID: 26149045
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Bivalirudin anticoagulation for left ventricular assist device implantation on an extracorporeal life support system in patients with heparin-induced thrombocytopenia antibodies.
    Ljajikj E; Zittermann A; Morshuis M; Börgermann J; Ruiz-Cano M; Schoenbrodt M; Gummert J; Koster A
    Interact Cardiovasc Thorac Surg; 2017 Dec; 25(6):898-904. PubMed ID: 29049666
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Managing the Precarious Hemostatic Balance during Extracorporeal Life Support: Implications for Coagulation Laboratories.
    Winkler AM
    Semin Thromb Hemost; 2017 Apr; 43(3):291-299. PubMed ID: 28166602
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Activation of the clotting system: heparin-coated versus non coated systems for extracorporeal circulation.
    Urlesberger B; Zobel G; Rödl S; Dacar D; Friehs I; Leschnik B; Muntean W
    Int J Artif Organs; 1997 Dec; 20(12):708-12. PubMed ID: 9506788
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Thrombogenicity is not reduced when heparin and phospholipid bonded circuits are used in a rabbit model of extracorporeal circulation.
    Meinhardt JP; Annich GM; Miskulin J; Kawai T; Ashton BA; Bartlett RH
    ASAIO J; 2003; 49(4):395-400. PubMed ID: 12918580
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Toward an artificial endothelium: Development of blood-compatible surfaces for extracorporeal life support.
    Roberts TR; Garren MRS; Handa H; Batchinsky AI
    J Trauma Acute Care Surg; 2020 Aug; 89(2S Suppl 2):S59-S68. PubMed ID: 32251267
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A bioinspired omniphobic surface coating on medical devices prevents thrombosis and biofouling.
    Leslie DC; Waterhouse A; Berthet JB; Valentin TM; Watters AL; Jain A; Kim P; Hatton BD; Nedder A; Donovan K; Super EH; Howell C; Johnson CP; Vu TL; Bolgen DE; Rifai S; Hansen AR; Aizenberg M; Super M; Aizenberg J; Ingber DE
    Nat Biotechnol; 2014 Nov; 32(11):1134-40. PubMed ID: 25306244
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Coagulation and anticoagulation in extracorporeal membrane oxygenation.
    Muntean W
    Artif Organs; 1999 Nov; 23(11):979-83. PubMed ID: 10564301
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Evaluation of Duraflo II heparin coating in prolonged extracorporeal membrane oxygenation.
    Toomasian JM; Hsu LC; Hirschl RB; Heiss KF; Hultquist KA; Bartlett RH
    ASAIO Trans; 1988; 34(3):410-4. PubMed ID: 3196539
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effects of heparin-coating of cardiopulmonary bypass circuits on leukocytes during simulated extracorporeal circulation.
    Borowiec J; Jaramillo A; Venge P; Nilsson L; Thelin S
    Cardiovasc Surg; 1997 Dec; 5(6):568-73. PubMed ID: 9423940
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Reduction of cell surface attachment in experimental hydrocephalus using a novel ventricular catheter with modified tethered liquid perfluorocarbon.
    Garcia-Bonilla M; Harris CA; Bandyopadhyay S; Moore J; Horbatiuk J; Limbrick DD; Swarup R; Crouthamel J; Jones A; Khasawneh A; Petroj A; Hehar S; Sierra M; Anderson J; Murray R; Talcott MR; McAllister JP
    J Neurosurg; 2024 Mar; 140(3):627-638. PubMed ID: 37542436
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.